1. United States Stocks

  2. •

    Health technology

  3. •

    Biotechnology
Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

110.35
EUR
+0.55
(+0.50%)
2.99EPS
22.26P/E
7.82BMarket Cap
Nov 09Next Earn

No stock splits recorded

Our records contain no stock splits for Halozyme Therapeutics, Inc. (XETR:RV7).

Stock splits API